Topics

Daiichi launches Vanflyta for AML in Japan

06:35 EDT 11 Oct 2019 | SmartBrief

Daiichi Sankyo's Vanflyta, or quizartinib, is now being sold in Japan to patients with relapsed/refractory FLT3-ITD acute my -More

Original Article: Daiichi launches Vanflyta for AML in Japan

NEXT ARTICLE

More From BioPortfolio on "Daiichi launches Vanflyta for AML in Japan"

Quick Search